[1]
|
Rajasekaran, S., Vanderpump, M., Baldeweg, S., et al. (2011) UK Guidelines for the Management of Pituitary Apoplexy. Clinical Endocrinology, 74, 9-20. https://doi.org/10.1111/j.1365-2265.2010.03913.x
|
[2]
|
Briet, C., Salenave, S., Bonneville, J.-F., Laws, E.R. and Chanson, P. (2015) Pituitary Apoplexy. Endocrine Reviews, 36, 622-645. https://doi.org/10.1210/er.2015-1042
|
[3]
|
Pal, A., Capatina, C., Tenreiro, A.P., et al. (2011) Pituitary Apoplexy in Non-Functioning Pituitary Adenomas: Long Term Follow Up Is Important Because of Significant Numbers of Tumour Recurrences. Clinical Endocrinology, 75, 501-504. https://doi.org/10.1111/j.1365-2265.2011.04068.x
|
[4]
|
Brougham, M., Heusner, A.P. and Adams, R.D. (1950) Acute Degenerative Changes in Adenomas of the Pituitary Body—With Special Reference to Pituitary Apoplexy. Journal of Neurosurgery, 7, 421-439.
https://doi.org/10.3171/jns.1950.7.5.0421
|
[5]
|
Wildemberg, L.E., Glezer, A., Bronstein, M.D. and Gadelha, M.R. (2018) Apoplexy in Nonfunctioning Pituitary Adenomas. Pituitary, 21, 138-144. https://doi.org/10.1007/s11102-018-0870-x
|
[6]
|
Barkhoudarian, G. and Kelly, D.F. (2019) Pituitary Apoplexy. Neurosurgery Clinics of North America, 30, 457-463.
https://doi.org/10.1016/j.nec.2019.06.001
|
[7]
|
Möller-Goede, D.L., Brändle, M., Landau, K., et al. (2011) Pituitary Apoplexy: Re-Evaluation of Risk Factors for Bleeding into Pituitary Adenomas and Impact on Outcome. European Journal of Endocrinology, 164, 37-43.
https://doi.org/10.1530/EJE-10-0651
|
[8]
|
Giammattei, L., Mantovani, G., Carrabba, G., et al. (2016) Pituitary Apoplexy: Considerations on a Single Center Experience and Review of the Literature. Journal of Endocrinological Investigation, 39, 739-746.
https://doi.org/10.1007/s40618-015-0424-2
|
[9]
|
Randeva, H.S., Schoebel, J., Byrne, J., Esiri, M., Adams, C.B.T. and Wass, J.A.H. (1999) Classical Pituitary Apoplexy: Clinical Features, Management and Outcome. Clinical Endocrinology, 51, 181-188.
https://doi.org/10.1046/j.1365-2265.1999.00754.x
|
[10]
|
Dubuisson, A.S., Beckers, A. and Stevenaert, A. (2007) Classical Pituitary Tumour Apoplexy: Clinical Features, Management and Outcomes in a Series of 24 Patients. Clinical Neurology and Neurosurgery, 109, 63-67.
https://doi.org/10.1016/j.clineuro.2006.01.006
|
[11]
|
da Motta, L.A., de Mello, P.A., de Lacerda, C.M., Neto, A.P., da Motta, L.D. and Filho, M.F. (1999) Pituitary Apoplexy. Clinical Course, Endocrine Evaluations and Treatment Analysis. Journal of Neurosurgical Sciences, 43, 25-36.
|
[12]
|
Wakai, S., Fukushima, T., Teramoto, A. and Sano, K. (1981) Pituitary Apoplexy: Its Incidence and Clinical Significance. Journal of Neurosurgery, 55, 187-193. https://doi.org/10.3171/jns.1981.55.2.0187
|
[13]
|
Jane, J.A., Semple, P.L. and Laws, E.R. (2007) Clinical Relevance of Precipitating Factors in Pituitary Apoplexy. Neurosurgery, 61, 956-961. https://doi.org/10.1227/01.neu.0000303191.57178.2a
|
[14]
|
Biousse, V., Newman, N.J. and Oyesiku, N.M. (2001) Precipitating Factors in Pituitary Apoplexy. Journal of Neurology, Neurosurgery & Psychiatry, 71, 542-545. https://doi.org/10.1136/jnnp.71.4.542
|
[15]
|
Naito, Y., Mori, J., Tazoe, J., et al. (2019) Pituitary Apoplexy after Cardiac Surgery in a 14-Year-Old Girl with Carney Complex: A Case Report. Endocrine Journal, 66, 1117-1123. https://doi.org/10.1507/endocrj.EJ19-0183
|
[16]
|
Khandelwal, M., et al. (2005) Pituitary Apoplexy Following Bilateral Total Knee Arthroplasty. Postgraduate Medicine, 51, 155-156.
|
[17]
|
Ahmad, F.U., Pandey, P. and Mahapatra, A.K. (2005) Post Operative “Pituitary Apoplexy” in Giant Pituitary Adenomas: A Series of Cases. Neurology India, 53, 236-238. https://doi.org/10.4103/0028-3886.16933
|
[18]
|
Gupta, P. and Dutta, P. (2018) Landscape of Molecular Events in Pituitary Apoplexy. Frontiers in Endocrinology, 9, 107. https://doi.org/10.3389/fendo.2018.00107
|
[19]
|
Xiao, Z., Liu, Q., Mao, F., et al. (2011) TNF-Alpha-Induced VEGF and MMP-9 Expression Promotes Hemorrhagic Transformation in Pituitary Adenomas. International Journal of Molecular Sciences, 12, 4165-4179.
https://doi.org/10.3390/ijms12064165
|
[20]
|
Mccoll, B.W., Rose, N., Robson, F.H., et al. (2010) Increased Brain Microvascular MMP-9 and Incidence of Haemorrhagic Transformation in Obese Mice after Experimental Stroke. Journal of Cerebral Blood Flow & Metabolism, 30, 267-272. https://doi.org/10.1038/jcbfm.2009.217
|
[21]
|
Pei, L. and Melmed, S. (1997) Isolation and Characterization of a Pituitary Tumor Transforming Gene (PTTG). Molecular Endocrinology, 11, 433-441. https://doi.org/10.1210/mend.11.4.9911
|
[22]
|
Ishikawa, H., Heaney, A.P., Yu, R., Horwitz, G.A. and Melmed, S. (2001) Human Pituitary Tumor-Transforming Gene Induces Angiogenesis. The Journal of Clinical Endocrinology & Metabolism, 86, 867-874.
https://doi.org/10.1210/jc.86.2.867
|
[23]
|
Berry, K.K., Varney, M.L., Dave, B.J., et al. (2001) Expression of Interleukin-8 in Human Metastatic Endometrial Carcinoma Cells and Its Regulation by Inflammatory Cytokines. International Journal of Gynecological Cancer, 11, 54-60. https://doi.org/10.1046/j.1525-1438.2001.011001054.x
|
[24]
|
Salehi, F., Agur, A., Scheithauer, B.W., Kovacs, K., Lloyd, R.V. and Cusimano, M. (2009) Ki-67 in Pituitary Neoplasms: A Review Part I. Neurosurgery, 65, 429-437. https://doi.org/10.1227/01.NEU.0000349930.66434.82
|
[25]
|
Verrees, M., Arafah, B.M. and Selman, W.R. (2004) Pituitary Tumor Apoplexy: Characteristics, Treatment, and Outcomes. Neurosurgical Focus, 16, E6. https://doi.org/10.3171/foc.2004.16.4.7
|
[26]
|
Bujawansa, S., Thondam, S.K., Steele, C., et al. (2014) Presentation, Management and Outcomes in Acute Pituitary Apoplexy: A Large Single-Centre Experience from the United Kingdom. Clinical Endocrinology, 80, 419-424.
https://doi.org/10.1111/cen.12307
|
[27]
|
Ayuk, J., McGregor, E.J., Mitchell, R.D. and Gittoes, N.J. (2004) Acute Management of Pituitary Apoplexy-Surgery or Conservative Management? Clinical Endocrinology, 61, 747-752. https://doi.org/10.1111/j.1365-2265.2004.02162.x
|
[28]
|
尹宏伟, 李卓群, 王宇翔, 等. 垂体腺瘤梗塞型卒中患者术前内分泌学特征初探[J]. 中华神经医学杂志, 2020, 19(6): 552-556.
|
[29]
|
王任直, 任祖渊, 苏长保, 等. 垂体腺瘤卒中的诊断和治疗(附49例报告) [J]. 中华神经外科杂志, 1995, 11(5): 255-258.
|
[30]
|
姚刚, 郭依廷. 垂体瘤卒中的MRI影像学表现分析[J]. 中国中西医结合影像学杂志, 2011, 9(2): 118-119+125.
|
[31]
|
Tosaka, M., Sato, N., Hirato, J., et al. (2007) Assessment of Hemorrhage in Pituitary Macroadenoma by T2*-Weighted Gradient-Echo MR Imaging. American Journal of Neuroradiology, 10, 2023-2029. https://doi.org/10.3174/ajnr.A0692
|
[32]
|
Arita, K., Kurisu, K., Tominaga, A., et al. (2001) Thickening of Sphenoid Sinus Mucosa during the Acute Stage of Pituitary Apoplexy. Neurosurgery, 95, 897-901. https://doi.org/10.3171/jns.2001.95.5.0897
|
[33]
|
尹宏伟, 李环廷, 李卓群, 等. 垂体腺瘤梗死性卒中MRI影像学特征初步研究[J]. 中国微侵袭神经外科杂志, 2020, 25(7): 310-313.
|
[34]
|
Pelkonen, R., Kuusisto, A., Salmi, J., et al. (1978) Pituitary Function after Pituitary Apoplexy. The American Journal of Medicine, 65, 773-778. https://doi.org/10.1016/0002-9343(78)90795-7
|
[35]
|
Turgut, M., Özsunar, Y., Başak, S., Guney, E., Kır, E. and Meteoğlu, İ. (2010) Pituitary Apoplexy: An Overview of 186 Cases Published during the Last Century. Acta Neurochirurgica, 152, 749-761.
https://doi.org/10.1007/s00701-009-0595-8
|
[36]
|
Barkhoudarian, G. and Kelly, D.F. (2019) Pituitary Apoplexy. Neurosurgery Clinics of North America, 30, 457-463.
https://doi.org/10.1016/j.nec.2019.06.001
|
[37]
|
Semple, P., Webb, M., de Villiers, J., et al. (2005) Pituitary Apoplexy. Neurosurgery, 56, 65-73.
https://doi.org/10.1227/01.NEU.0000144840.55247.38
|